Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,282,553
-
Share change
-
+566,230
-
Total reported value
-
$115,340,713
-
Put/Call ratio
-
82%
-
Price per share
-
$4.75
-
Number of holders
-
52
-
Value change
-
-$3,854,371
-
Number of buys
-
29
-
Number of sells
-
33
Institutional Holders of PROTEOSTASIS THERAPEUTICS IN - COM (PTI) as of Q1 2018
As of 31 Mar 2018,
PROTEOSTASIS THERAPEUTICS IN - COM (PTI) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,282,553 shares.
The largest 10 holders included
NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, JENNISON ASSOCIATES LLC, RTW INVESTMENTS, LP, VANGUARD GROUP INC, Hillhouse Capital Management, Ltd., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Rock Springs Capital Management LP, and FIL Ltd.
This page lists
52
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.